Glitaris M 7.5 Forte Tablet SR
By Glitaris M
Rx
10 Tablet SR in a Strip

Composition
Pioglitazone(7.5mg) + Metformin(1000mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
July, 2026

liver
When using Glitaris M 7.5 Forte Tablet SR, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication. It is advised to start with a low dose if you have mild to moderate liver disease. However, it is not recommended to use Glitaris M 7.5 Forte Tablet SR if you have severe liver disease. It is best to consult your doctor before using this medication if you have any liver problems.

kidney
Glitaris M 7.5 Forte Tablet SR requires caution in patients with kidney disease. Dosage adjustment may be necessary, and it is not advised for severe kidney disease. Regular kidney function tests are recommended during treatment. Please consult your doctor.

alcohol
It is unsafe to consume alcohol with Glitaris M 7.5 Forte Tablet SR.

driving
When taking Glitaris M 7.5 Forte Tablet SR, be cautious while driving. Low or high blood sugar levels can affect your driving abilities. Avoid driving if you experience these symptoms.

pregnancy
Glitaris M 7.5 Forte Tablet SR may not be safe for use during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a thorough evaluation of benefits and risks before taking this medication.

breastfeeding
Caution is advised when breastfeeding while taking Glitaris M 7.5 Forte Tablet SR. Limited data shows potential harm to the baby as the drug may pass into breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹76.23
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025